Eisai
4523.T
#1927
Rank
NZ$14.51 B
Marketcap
$51.48
Share price
0.67%
Change (1 day)
-40.09%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2023 (TTM): $3.54

According to Eisai's latest financial reports the company's current EPS (TTM) is $3.74. In 2022 the company made an earnings per share (EPS) of $2.75 a decrease over its 2021 EPS that were of $12.19.

EPS history for Eisai from 2009 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$3.5428.95%
2022$2.75-77.48%
2021$12.19-41.88%
2020$20.97-0.94%
2019$21.1752.59%
2018$13.87124.17%
2017$6.19-49.42%
2016$12.2437.08%
2015$8.93-11.75%
2014$10.11-3.23%
2013$10.45-18.56%
2012$12.84-15.51%
2011$15.19-3.75%
2010$15.78-1.36%
2009$16.00